- Home
- RVTY vs EXEL Comparison
RVTY vs EXEL Comparison
Compare RVTY & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- EXEL
- Stock Information
- Founded
- RVTY 1937
- EXEL 1994
- Country
- RVTY United States
- EXEL United States
- Employees
- RVTY N/A
- EXEL N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVTY Industrials
- EXEL Health Care
- Exchange
- RVTY Nasdaq
- EXEL Nasdaq
- Market Cap
- RVTY 9.9B
- EXEL 11.1B
- IPO Year
- RVTY N/A
- EXEL 2000
- Fundamental
- Price
- RVTY $105.82
- EXEL $42.90
- Analyst Decision
- RVTY Buy
- EXEL Buy
- Analyst Count
- RVTY 13
- EXEL 24
- Target Price
- RVTY $112.92
- EXEL $44.73
- AVG Volume (30 Days)
- RVTY 1.8M
- EXEL 2.8M
- Earning Date
- RVTY 10-27-2025
- EXEL 11-04-2025
- Dividend Yield
- RVTY 0.26%
- EXEL N/A
- EPS Growth
- RVTY N/A
- EXEL 53.55
- EPS
- RVTY 1.99
- EXEL 2.38
- Revenue
- RVTY $2,813,367,000.00
- EXEL $2,288,218,000.00
- Revenue This Year
- RVTY $5.37
- EXEL $9.14
- Revenue Next Year
- RVTY $3.07
- EXEL $12.51
- P/E Ratio
- RVTY $53.27
- EXEL $18.15
- Revenue Growth
- RVTY 3.37
- EXEL 9.93
- 52 Week Low
- RVTY $81.36
- EXEL $31.90
- 52 Week High
- RVTY $128.29
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- RVTY 72.45
- EXEL 60.15
- Support Level
- RVTY $89.65
- EXEL $41.65
- Resistance Level
- RVTY $95.79
- EXEL $42.99
- Average True Range (ATR)
- RVTY 3.01
- EXEL 1.25
- MACD
- RVTY 1.14
- EXEL 0.07
- Stochastic Oscillator
- RVTY 98.38
- EXEL 79.18
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.